Zhuomiao Ye
机构:Chongqing University, Chongqing Three Gorges Central Hospital, Chongqing Three Gorges University · ORCID:0000-0003-2983-5944
发表论文 32 篇 · 总被引 316 次 · h-index 9
代表论文
- Cost‐effectiveness analysis of sintilimab plus IBI305 versus sorafenib for unresectable hepatic cell carcinoma in China (2023 · Cancer Medicine · 被引 15)
- The association between single nucleotide polymorphisms and ovarian cancer risk: A systematic review and network meta‐analysis (2022 · Cancer Medicine · 被引 14)
- A systematic review and network meta-analysis of single nucleotide polymorphisms associated with pancreatic cancer risk (2020 · Aging · 被引 14)
- CT-based peritumoral radiomics nomogram on prediction of response and survival to induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma (2024 · Journal of Cancer Research and Clinical Oncology · 被引 9)
- Cost-effectiveness analysis of pembrolizumab vs. chemotherapy as second-line treatment for advanced esophageal carcinoma in the United States (2022 · Frontiers in Public Health · 被引 9)
- Cost‐effectiveness analysis of pembrolizumab plus chemotherapy versus chemotherapy as the first‐line treatment for advanced esophageal cancer (2022 · Cancer Medicine · 被引 9)